Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tianying Yu
Preclinical Evaluation of 99mTc Direct Labeling ZHER2:V2 for HER2 Positive Tumors Imaging
Oncology Letters
Cancer Research
Oncology
Related publications
Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Pre-Clinical Evaluation of [111In]-Benzyl-Dota-Zher2:342, a Potential Agent for Imaging of HER2 Expression in Malignant Tumors
International Journal of Molecular Medicine
Medicine
Genetics
All HER2-Positive Tumors Are Not Created Equal
Annals of Surgical Oncology
Oncology
Surgery
Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors
Contrast Media and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Novel Arginine-Containing Macrocyclic MMP Inhibitors: Synthesis, 99mTc-Labeling, and Evaluation
Scientific Reports
Multidisciplinary
Design, Synthesis and Labeling of Tripeptide Derivatives With 99mTc as Hypoxia Imaging Agents
Iranian South Medical Journal
In Vitro Evaluation of a Specific Radiochemical Compound Based on 99mTc-Labeled DARPinG3 for Radionuclide Imaging of Tumors Overexpressing Her-2/Neu
Clinically Applicable Magnetic-Labeling of Natural Killer Cells for MRI of Transcatheter Delivery to Liver Tumors: Preclinical Validation for Clinical Translation
Nanomedicine
Development
Materials Science
Nanoscience
Medicine
Bioengineering
Nanotechnology
Biomedical Engineering
In VivoandIn VitroStudies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors
Cancer Biotherapy and Radiopharmaceuticals
Nuclear Medicine
Radiology
Pharmacology
Cancer Research
Oncology
Imaging
Medicine
